Cargando…

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?

The ability to identify the broadest range of targetable gene fusions is crucial to facilitate personalized therapy selection for advanced lung adenocarcinoma (LuADs) patients harboring targetable receptor tyrosine kinase (RTK) genomic alterations. In order to evaluate the most effective testing app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pecciarini, Lorenza, Brunetto, Emanuela, Grassini, Greta, De Pascali, Valeria, Ogliari, Francesca Rita, Talarico, Anna, Marra, Giovanna, Magliacane, Gilda, Redegalli, Miriam, Arrigoni, Gianluigi, Lazzari, Chiara, Gregorc, Vanesa, Bulotta, Alessandra, Doglioni, Claudio, Cangi, Maria Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137127/ https://www.ncbi.nlm.nih.gov/pubmed/37190044 http://dx.doi.org/10.3390/cells12081135

Ejemplares similares

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities
por: Lazzari, Chiara, et al.
Publicado: (2020)

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2021)

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!
por: Magliacane, Gilda, et al.
Publicado: (2022)

Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics
por: Magliacane, Gilda, et al.
Publicado: (2015)

Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
por: Lazzari, Chiara, et al.
Publicado: (2022)

Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies
por: Lazzari, Chiara, et al.
Publicado: (2023)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
por: Lazzari, Chiara, et al.
Publicado: (2021)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies
por: Petrelli, Fausto, et al.
Publicado: (2018)

KRAS in NSCLC: State of the Art and Future Perspectives
por: Cascetta, Priscilla, et al.
Publicado: (2022)

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
por: Tassi, Elena, et al.
Publicado: (2023)

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer
por: Lazzari, Chiara, et al.
Publicado: (2017)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
por: Carretta, Angelo, et al.
Publicado: (2020)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018)

Targeted Therapies in Early Stage NSCLC: Hype or Hope?
por: Friedlaender, Alex, et al.
Publicado: (2020)

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review
por: Mirabile, Aurora, et al.
Publicado: (2019)

Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature
por: Mirabile, Aurora, et al.
Publicado: (2020)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
por: Mirabile, Aurora, et al.
Publicado: (2020)

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
por: Papadopoulou, Eirini, et al.
Publicado: (2019)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
por: Corti, Angelo, et al.
Publicado: (2013)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma
por: Paolino, Giovanni, et al.
Publicado: (2020)

Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients
por: He, Changlong, et al.
Publicado: (2021)

Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
por: Cao, Wei, et al.
Publicado: (2019)

Analysis of Complementary Sex-Determiner (csd) Allele Diversity in Different Honeybee Subspecies from Italy Based on NGS Data
por: Paolillo, Gianluigi, et al.
Publicado: (2022)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies
por: Giovannini, Monica, et al.
Publicado: (2009)

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
por: Pujol, Jean-Louis, et al.
Publicado: (2021)

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients
por: Vollbrecht, Claudia, et al.
Publicado: (2018)

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
por: Sánchez‐Herrero, Estela, et al.
Publicado: (2021)

Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

Establishment and Characterization of PCL12, a Novel CD5(+) Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Orione, a web-based framework for NGS analysis in microbiology
por: Cuccuru, Gianmauro, et al.
Publicado: (2014)

Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs
por: Ma, Li, et al.
Publicado: (2021)

Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs
por: Morikawa, Kei, et al.
Publicado: (2022)

Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic
por: Valsecchi, Davide, et al.
Publicado: (2023)

Addendum to the NGS report
por: CERN. Geneva. SPS-PS Experiments Committee
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_cvca7kqlgulpftf8ipngrgnnji